name: Trazodone only product in oral dose form


name: Treosulfan only product in oral dose form


name: Treosulfan only product in parenteral dose form


name: Tretinoin only product in cutaneous dose form


name: Tretinoin only product in oral dose form


name: Triamcinolone only product in cutaneous dose form


name: Triamcinolone only product in nasal dose form


name: Triamcinolone only product in oral dose form


name: Triamcinolone only product in oromucosal dose form


name: Triamcinolone only product in otic dose form


name: Triamcinolone only product in parenteral dose form


name: Triamcinolone only product in pulmonary dose form


name: Triamterene only product in oral dose form


name: Triazolam only product in oral dose form


name: Trichlormethiazide only product in oral dose form


name: Triclabendazole only product in oral dose form


name: Triclofos only product in oral dose form


name: Triclosan only product in cutaneous dose form


name: Trientine only product in oral dose form


name: Triethanolamine only product in otic dose form


name: Trifluoperazine only product in oral dose form


name: Trifluoperazine only product in parenteral dose form


name: Trifluridine only product in ocular dose form


name: Trihexyphenidyl only product in oral dose form


name: Trilostane only product in oral dose form


name: Trimethaphan only product in parenteral dose form


name: Trimethadione only product in oral dose form


name: Trimethobenzamide only product in oral dose form


name: Trimethobenzamide only product in parenteral dose form


name: Trimethobenzamide only product in rectal dose form


name: Trimethoprim only product in ocular dose form


name: Trimethoprim only product in oral dose form


name: Trimethoprim only product in parenteral dose form


name: Trimipramine only product in oral dose form


name: Tripelennamine only product in oral dose form


name: Tripotassium dicitratobismuthate only product in oral dose form


name: Triptorelin only product in parenteral dose form


name: Troglitazone only product in oral dose form


name: Troleandomycin only product in oral dose form


name: Tropicamide only product in ocular dose form


name: Tropisetron only product in oral dose form


name: Tropisetron only product in parenteral dose form


name: Trovafloxacin only product in oral dose form


name: Trovafloxacin only product in parenteral dose form


name: Tryptophan only product in oral dose form


name: Tyloxapol only product in ocular dose form


name: Tyloxapol only product in pulmonary dose form


name: Ulipristal only product in oral dose form


name: Umeclidinium only product in pulmonary dose form


name: Undecylenic acid only product in cutaneous dose form


name: Unoprostone isopropyl only product in ocular dose form


name: Urea only product in cutaneous dose form


name: Urea only product in parenteral dose form


name: Valacyclovir only product in oral dose form


name: Valbenazine only product in oral dose form


name: Valdecoxib only product in oral dose form


name: Valganciclovir only product in oral dose form


name: Valproic acid only product in oral dose form


name: Valproic acid only product in parenteral dose form


name: Valsartan only product in oral dose form


name: Vancomycin only product in oral dose form


name: Vancomycin only product in parenteral dose form


name: Vardenafil only product in oral dose form


name: Varenicline only product in oral dose form


name: Vecuronium only product in parenteral dose form


name: Vemurafenib only product in oral dose form


name: Venetoclax only product in oral dose form


name: Venlafaxine only product in oral dose form


name: Verapamil only product in oral dose form


name: Verapamil only product in parenteral dose form


name: Verteporfin only product in parenteral dose form


name: Vestronidase alfa only product in parenteral dose form


name: Vidarabine only product in ocular dose form


name: Vigabatrin only product in oral dose form


name: Vilazodone only product in oral dose form


name: Vildagliptin only product in oral dose form


name: Vinblastine only product in parenteral dose form


name: Vindesine only product in parenteral dose form


name: Vinorelbine only product in parenteral dose form


name: Vismodegib only product in oral dose form


name: Vorapaxar only product in oral dose form


name: Voriconazole only product in oral dose form


name: Voriconazole only product in parenteral dose form


name: Vorinostat only product in oral dose form


name: Vortioxetine only product in oral dose form


name: Warfarin only product in parenteral dose form


name: Water only product in parenteral dose form


name: Witch hazel only product in cutaneous dose form


name: Witch hazel only product in ocular dose form


name: Witch hazel only product in rectal dose form


name: Witch hazel only product in vaginal dose form


name: Xenon-133 only product in parenteral dose form


name: Xenon-133 only product in pulmonary dose form


name: Xylometazoline only product in nasal dose form


name: Xylometazoline only product in ocular dose form


name: Xylometazoline only product in oral dose form


name: Yohimbine only product in oral dose form


name: Yttrium-90 only product in parenteral dose form


name: Zafirlukast only product in oral dose form


name: Zalcitabine only product in oral dose form


name: Ziconotide only product in parenteral dose form


name: Zidovudine only product in oral dose form


name: Zidovudine only product in parenteral dose form


name: Zinc acetate only product in cutaneous dose form


name: Zinc acetate only product in oral dose form


name: Zinc gluconate only product in nasal dose form


name: Zinc only product in cutaneous dose form


name: Zinc only product in parenteral dose form


name: Zinc sulfate only product in ocular dose form


name: Zinc sulfate only product in oral dose form


name: Ziprasidone only product in oral dose form


name: Ziprasidone only product in parenteral dose form


name: Zolmitriptan only product in nasal dose form


name: Zolmitriptan only product in oral dose form


name: Zonisamide only product in oral dose form


name: Zopiclone only product in oral dose form


name: Zuclopenthixol only product in oral dose form


name: Zuclopenthixol only product in parenteral dose form


name: Invitation to participate in research study


name: Target serum high density lipoprotein cholesterol level


name: Target serum low density lipoprotein cholesterol level


name: Target serum non high density lipoprotein cholesterol level


name: Construction of interposition anastomosis using tissue engineered blood vessel


name: Harvest of bone graft from tibia and fibula


name: Harvest of bone graft from tarsal bone and metatarsal bone


name: Construction of interposition anastomosis of femoro-popliteal artery graft using tissue engineered blood vessel


name: Dipivefrin only product in ocular dose form


name: Echothiophate only product in ocular dose form


name: Isoflurophate only product in ocular dose form


name: Demecarium only product in ocular dose form


name: Mineral oil only product in oral dose form


name: Ancrod only product in parenteral dose form


name: Dabigatran only product in oral dose form


name: Family history of polycystic ovary syndrome


name: Protein C only product in parenteral dose form


name: Porcine heparin only product in parenteral dose form


name: Ardeparin only product in parenteral dose form


name: Recombinant antihemophilic factor pegylated liposome only product


name: Recombinant antihemophilic factor pegylated liposome only product in parenteral dose form


name: Chronic Obstructive Pulmonary Disease Assessment Test scale


name: Coagulation factor IX only product in parenteral dose form


name: Assessment using CPT (Cognitive Performance Test)


name: CPT (Cognitive Performance Test) total score


name: Coagulation factor VIIa only product in parenteral dose form


name: Assessment using AIMS2 (Arthritis Impact Measurement Scales 2)


name: APACHE II (Acute Physiology and Chronic Health Evaluation II) score


name: Assessment using APACHE II (Acute Physiology and Chronic Health Evaluation II)


name: Assessment using APACHE III (Acute Physiology and Chronic Health Evaluation III)


name: APACHE III (Acute Physiology and Chronic Health Evaluation III) score


name: Coagulation factor XI only product in parenteral dose form


name: Assessment using AIDS Risk Behavior Knowledge Test


name: AIDS Risk Behavior Knowledge Test total score


name: Fremanezumab only product in parenteral dose form


name: Moxetumomab pasudotox only product in parenteral dose form


name: Porcine factor VIII only product in parenteral dose form


name: Nonacog alfa only product in parenteral dose form


name: Albutrepenonacog alfa only product in parenteral dose form


name: Efmoroctocog alfa only product in parenteral dose form


name: Moroctocog alfa only product in parenteral dose form


name: Octocog alfa only product in parenteral dose form


name: Human fibrinogen only product in parenteral dose form


name: Thrombin only product in cutaneous dose form


name: ERS-extended, rotated, and sidebent vertebral position


name: NSR-neutral, sidebent, and rotated vertebral position


name: Reslizumab only product in parenteral dose form


name: Brivaracetam only product in parenteral dose form


name: Brivaracetam only product in oral dose form


name: Bilateral instability of joints of knees


name: Elbasvir and grazoprevir only product in oral dose form


name: Pegvaliase only product in parenteral dose form


name: Secukinumab only product in parenteral dose form


name: Mass of subcutaneous tissue of right lower leg


name: Mass of subcutaneous tissue of left lower leg


name: Nodule of subcutaneous tissue of left lower leg


name: Nodule of subcutaneous tissue of right lower leg


name: Doppler ultrasonography of aorta and artery of lower limb


name: Daclizumab only product in parenteral dose form


name: Macimorelin only product in oral dose form


name: Netarsudil only product in ocular dose form


name: Moxidectin only product in oral dose form


name: Fosnetupitant- and palonosetron-containing product


name: Fosnetupitant and palonosetron only product


name: Fosnetupitant and palonosetron only product in oral dose form


name: Fosnetupitant and palonosetron only product in parenteral dose form


name: Panobinostat only product in oral dose form


name: Ivabradine only product in oral dose form


name: Brexpiprazole only product in oral dose form


name: Sugammadex only product in parenteral dose form


name: Avibactam and ceftazidime only product in parenteral dose form


name: Sonidegib only product in oral dose form


name: Mepolizumab only product in parenteral dose form


name: Osimertinib only product in oral dose form


name: Alectinib only product in oral dose form


name: Necitumumab only product in parenteral dose form


name: Daratumumab only product in parenteral dose form


name: Elotuzumab only product in parenteral dose form


name: Alirocumab only product in parenteral dose form


name: Duvelisib only product in oral dose form


name: Cholic acid only product in oral dose form


name: Deoxycholic acid only product in parenteral dose form


name: Selexipag only product in oral dose form


name: Doppler ultrasonography of aorta and femoral artery


name: Fluoroscopic angiography of abdominal and pelvic vascular structure with contrast


name: FRS - flexed, rotated, and sidebent vertebral position


name: Angiography of bilateral femoral arteries


name: Fluoroscopy guided lithotripsy of left kidney


name: Fluoroscopy guided lithotripsy of right kidney


name: Sterile non-animal derived oral wound dressing


name: electronic walker for gait rehabilitation


name: Dacomitinib only product in oral dose form


name: Doravirine only product in oral dose form


name: Doravirine and lamivudine and tenofovir only product


name: Doravirine- and lamivudine- and tenofovir-containing product


name: Doravirine and lamivudine and tenofovir only product in oral dose form


name: MRI of right external auditory meatus with contrast


name: Gelatin only product in cutaneous dose form


name: Oxidized cellulose only product in cutaneous dose form


name: Anti-inhibitor coagulant complex only product in parenteral dose form


name: Aprotinin only product in parenteral dose form


name: Carbazochrome only product in oral dose form


name: Cemiplimab only product in parenteral dose form


name: Administration of prostaglandin via oral route


name: MRI of left external auditory meatus with contrast


name: MRI of both external auditory meatuses with contrast


name: Vitamin B12 and/or vitamin B12 derivative


name: Vitamin B12 and/or vitamin B12 derivative-containing product


name: Sarecycline only product in oral dose form


name: Omadacycline only product in oral dose form


name: Omadacycline only product in parenteral dose form


name: Assessment using Medical Outcomes Study 20-item Short Form Health Survey


name: Cyclic citrullinated peptide antibody measurement above reference range


name: Assessment using MSAT (Minnesota Sedation Assessment Tool)


name: Elapegademase only product in parenteral dose form


name: CT triple phase angiography with contrast for TAVI (transcatheter aortic valve implantation) planning


name: Transcutaneous microwave ablation of sweat gland


name: Acinetobacter baumannii or Acinetobacter nosocomialis group


name: Fluciclovine (18-F) only product in parenteral dose form


name: Defibrotide only product in parenteral dose form


name: Lindane only product in cutaneous dose form


name: Gamolenic acid only product in oral dose form


name: Talazoparib only product in oral dose form


name: Revision of decompressive excision of lamina of lumbar vertebra


name: Para-aminosalicylic acid only product in oral dose form


name: Nodule of subcutaneous tissue of upper limb


name: Nodule of subcutaneous tissue of finger of hand


name: Nodule of subcutaneous tissue of left upper limb


name: Nodule of subcutaneous tissue of right upper limb


name: Nodule of subcutaneous tissue of left hand


name: Nodule of subcutaneous tissue of right hand


name: Nodule of subcutaneous tissue of finger of left hand


name: Nodule of subcutaneous tissue of finger of right hand


name: Nodule of subcutaneous tissue of lower limb


name: Nodule of subcutaneous tissue of right lower limb


name: Nodule of subcutaneous tissue of left lower limb


name: Nodule of subcutaneous tissue of right foot


name: Nodule of subcutaneous tissue of left foot


name: Nodule of subcutaneous tissue of abdominal wall


name: Nodule of subcutaneous tissue of chest wall


name: Galcanezumab only product in parenteral dose form


name: Amikacin liposome only product in pulmonary dose form


name: Levoleucovorin only product in parenteral dose form


name: Modified carbapenem inactivation technique


name: Antimicrobial surgical female underpants


name: nutritional therapy, ketogenic, milk based with soy 4.5 gram-153 kcal/100 mL ORAL LIQUID (ML)


name: multivitamin with minerals/ferrous sulfate 4.5 mg iron ORAL TABLET


name: CIDOFOVIR 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 0.03 g in 1 mL / HOMOSALATE 0.05 g in 1 mL / OCTISALATE 0.045 g in 1 mL / OXYBENZONE 0.033 g in 1 mL TOPICAL LOTION [LAB SERIES DAY RESCUE DEFENSE BROAD SPECTRUM SPF 35]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [Equate Sunscreen SPF 30 SPORT Broad Spectrum]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate SUNSCREEN spf 50 SPORT broadspectrum]


name: Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated


name: NIACINAMIDE 0.11 g in 5 mL TOPICAL LIQUID [De medicotem illuminating white cell ampoule]


name: OLEA EUROPAEA LEAF 8.0 mg in 800 mg / MYRRH 8.0 mg in 800 mg / NIACINAMIDE 16.0 mg in 800 mg VAGINAL TABLET [LA FEMME V Feminine Cleanser]


name: tablet rapid dissolve compounding base no.230


name: METHAZOLAMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL LOTION [CERAVE DEVELOPED WITH DERMATOLOGISTS HYDRATING SUNSCREEN SPF 30 FACE LIGHTWEIGHT, NON-GREASY FEEL 3 ESSENTIAL CERAMIDES NIACINAMIDE MINERAL SUNSCREEN]


name: TITANIUM DIOXIDE 90 mg in 1 mL / ZINC OXIDE 70 mg in 1 mL TOPICAL LOTION [Cerave Developed with Dermatologists Hydrating Sunscreen SPF 50 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [Equate Sunscreen SPF 70 SPORT Broad spectrum]


name: AVOBENZONE 3200 mg in 125 mL / OCTINOXATE 9472 mg in 125 mL / OCTOCRYLENE 2560 mg in 125 mL / OXYBENZONE 1280 mg in 125 mL TOPICAL EMULSION [CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING n]


name: OCTINOXATE 1815 mg in 30 mL / TITANIUM DIOXIDE 5558 mg in 30 mL TOPICAL LOTION [SHISEIDO SPORTS BB LIGHT]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [NeoStrata Sheer Hydration Sunscreen Broad Spectrum SPF 40]


name: Niacinamide 0.028 g in 1.4 g / Adenosine 0.0005 g in 1.4 g TOPICAL PATCH [ROSELLE TEA EYE GE L]


name: ZINC OXIDE 8 g in 100 g TOPICAL STICK [Badger BROAD SPECTRUM SPF 15 Lip Balm]


name: SET,INFUSION AUTOSOFT 90 TANDEM #1000277


name: CATHETER,EXTERNAL INTERM BARD #37103/37303


name: DRESSING,HYDROFERA BLUE 8IN X 8IN HBRT8080


name: DRESSING,HYDROFERA BLUE 4IN X 5IN HBRT4050


name: CATHETER,SUCTION,WHISTLE TIP 10-12FR BARD #0128100


name: DRESSING,MEPILEX BORDER 8.7IN X 9.8IN #282455


name: VAD DRIVELINE MAINTENANCE KIT CM#DT17870


name: nutritional therapy for tyrosinemia with iron 71 gram-357 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: tablet rapid dissolve compounding base no.230 MISCELL POWDER (GRAM)


name: emollient combination no.111 TOPICAL CREAM (ML)


name: gel-matrix pad dressing, silicone 2 1/2" X 2" TOPICAL PAD


name: Health Mart Nutrition Plus Shake (Milk Chocolate)


name: BETHANECHOL CHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: DORZOLAMIDE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Nutritional Supplement Oral Powder for Suspension [Similac Go & Grow HMO]


name: Emulsion, Multi Ingredient Topical application Emulsion [Penlen Spray Emulsion]


name: Zinc Oxide;Zinc Oxide 16%; 40% Multiple Routes Ointment [Boudreaux's Rash Kicking Kit]


name: digoxin, micronized 100 % MISCELL POWDER (GRAM)


name: Acetaminophen/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride;Acetaminophen/Diphenhydramine Hydrochloride/Phenylephrine Hydrochloride 500 MG-20 MG-10 MG; 650 MG-25 MG-10 MG Oral Packet [Severe Cold Value Pack]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g / OXYBENZONE 5 g in 100 g TOPICAL AEROSOL, SPRAY [UNCOMPLIKATED MAKEUP SETTING SPF 50]


name: candesartan, amlodipine and hydrochlorothiazide


name: cefpodoxime and beta-lactamase inhibitor


name: isoniazid, sulfamethoxazole and trimethoprim


name: ALLANTOIN 0.0864 g in 27 mL / SPIRULINA PLATENSIS 0.0675 g in 27 mL TOPICAL PATCH [Puriface Spirulina Eye Gel Masks]


name: SELEGILINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: VORICONAZOLE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 0.07 g in 1 g / TITANIUM DIOXIDE 0.053 g in 1 g / ZINC OXIDE 0.039 g in 1 g TOPICAL CREAM [BE THE SKIN NATURAL BASE SUN]


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) } Pack [Lojaimiess 91 Day]


name: Niacinamide 0.11 g in 5.5 g / Adenosine 0.002 g in 5.5 g TOPICAL PATCH [MEDIUS Heart Ppyoung Ppyoung Eye]


name: AVOBENZONE 2 g in 100 g / OCTINOXATE 6.5 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 1.5 g in 100 g TOPICAL STICK [ALOE UP SPORT NATURAL BALM SPF-15]


name: AVOBENZONE 2 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 3 g in 100 mL TOPICAL LOTION [ALOE UP SPORT SPF-15]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 15 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [ALOE UP SPORT SPF-50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL CREAM [Everyday Sunscreen with Sunflower Extract Broad Spectrum SPF 30]


name: Assessment using Transport Risk Index of Physiologic Stability


name: Transport Risk Index of Physiologic Stability


name: Review of prescription drug monitoring program record


name: Assessment using the Forgotten Joint Score


name: Suicide safety plan not given to caregiver


name: Suicide safety plan not given to patient


name: Assessment for residential mental healthcare services


name: Education about crisis intervention telephone number


name: Consultation for suicide risk management


name: History of admission to psychiatry department


name: Rewards and contingency management therapy


name: Counseling about firearm safety not done


name: Trophozoite of Endolimax nana or Iodamoeba butschlii


name: Cyst of Entamoeba histolytica and trophozoite of Entamoeba histolytica


name: Instability of acromioclavicular joint of bilateral shoulders


name: Instability of acromioclavicular joint of right shoulder


name: Instability of acromioclavicular joint of left shoulder


name: Deoxyribonucleic acid of Human herpes simplex virus type 2 not detected


name: Deoxyribonucleic acid of Human herpes simplex virus 1 not detected


name: Deoxyribonucleic acid of Human herpes simplex virus 1 detected


name: Deoxyribonucleic acid of Human herpes simplex virus 2 detected


name: Referral to CDC-recognized diabetes prevention program


name: Administration of pneumococcal 13-valent conjugate vaccine


name: Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml


name: Graft of skin to skin of external auditory canal (procedure)


name: Reconstruction of vagina with graft of skin


name: Encounter due to hormone replacement therapy


name: CHLOROXYLENOL 0.3 g in 100 mL TOPICAL SOAP [Dawn Ultra Antibacterial Hand Apple Blossom Scent]


name: dental abutment supported titanium crown


name: dental abutment supported titanium retainer crown for fixed partial denture


name: Views + lateral crosstable:Find:Pt:Lower extremity.bilateral>Hip:Doc:XR


name: Cream, Multi Ingredient;Cream, Multi Ingredient NA; NA Topical application Cream


name: 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10)


name: C Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Date and time of public health emergency:TmStp:Pt:^Event:Qn


name: Date and time of public health emergency


name: Date and time of risk assessment meeting


name: Date and time of risk assessment meeting:TmStp:Pt:^Event:Qn


name: PhenX - house rules about tobacco use protocol 711101:-:Pt:^Patient:-:PhenX


name: PhenX - house rules about tobacco use protocol 711101


name: HIV 1 integrase gene mutations (lab test)


name: Post Anesthetic Recovery score (assessment scale)


name: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20


name: Substance with orotate phosphoribosyltransferase inhibitor mechanism of action (substance)


name: Orotate phosphoribosyltransferase inhibitor (disposition)


name: Phosphoribosylglycinamide formyltransferase inhibitor (disposition)


name: Substance with sclerostin inhibitor mechanism of action (substance)


name: Sphingosine 1-phosphate receptor agonist (disposition)


name: Split thickness graft of skin to skin (procedure)


name: Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)


name: Vascular endothelial growth factor receptor antagonist (disposition)


name: Date and time rumor record was released:TmStp:Pt:^Event:Qn


name: Date and time report was received:TmStp:Pt:Report:Qn


name: K Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little k Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: K Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: little k Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Lived with someone who smoked regularly inside the home during childhood:Find:Pt:^Patient:Ord


name: Lived with someone who smoked regularly inside the home during childhood


name: PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score


name: PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0


name: PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score


name: PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0


name: PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: STarT Back Screening risk level:Find:Pt:^Patient:Ord:STarT Back


name: Microbiology - viral studies:Find:Pt:^Patient:Doc


name: Probability of an event occurring:Likelihood:Pt:^Event:Ord


name: PROMIS parent proxy positive affect - version 1.0 T-score


name: PROMIS parent proxy positive affect - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy psychological stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy psychological stress experiences - version 1.0 T-score


name: PROMIS parent proxy short form - anxiety 8a - version 2.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - anxiety 8a - version 2.0


name: PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score


name: PROMIS parent proxy short form - fatigue 10a - version 2.0


name: PROMIS self-efficacy for managing social interactions - version 1.0 T-score


name: PROMIS self-efficacy for managing social interactions - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS self-efficacy for managing symptoms - version 1.0 T-score


name: PROMIS self-efficacy for managing symptoms - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - dyspnea severity 10a - version 1.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - dyspnea severity 10a - version 1.0


name: PROMIS short form - dyspnea severity 10a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS


name: PROMIS short form - dyspnea severity 10a - version 1.0 raw score


name: PROMIS short form - physical function 10a - version 2.0:-:Pt:^Patient:-:PROMIS


name: Protein synthase inhibitor (disposition)


name: Substance with protein synthase inhibitor mechanism of action (substance)


name: Had both ovaries removed:Find:Pt:^Patient:Ord


name: PROMIS parent proxy short form - fatigue 10a - version 2.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score


name: PROMIS parent proxy short form - meaning and purpose 4a - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - meaning and purpose 4a - version 1.0


name: PROMIS parent proxy short form - meaning and purpose 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - meaning and purpose 4a - version 1.0 raw score


name: PROMIS parent proxy short form - meaning and purpose 8a - version 1.0


name: Human epidermal growth factor receptor 2 inhibitor (disposition)


name: Substance with phosphoribosylglycinamide formyltransferase inhibitor mechanism of action (substance)


name: Pyroglutamyl-peptidase I inhibitor (disposition)


name: Care team information panel:-:Pt:^Patient:-


name: Date of arrival at travel destination:Date:Pt:^Patient:Qn


name: Date of departure from travel destination


name: Date of departure from travel destination:Date:Pt:^Patient:Qn


name: Maternal discharge summary - recommended IHE set


name: Maternal discharge summary - recommended IHE set:-:Pt:{Setting}:-


name: Emergency response plan success analysis:Find:Pt:^Event:Nom


name: Emergency response plan target outcome:Find:Pt:^Event:Nom


name: Has automobile available for use:Find:Pt:^Patient:Ord


name: PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score


name: PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0


name: PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score


name: PROMIS short form - upper extremity 7a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - upper extremity 7a - version 2.0


name: PROMIS short form - upper extremity 7a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - upper extremity 7a - version 2.0 raw score


name: PROMIS smoking - coping expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Date range for emergency response plan:DateRange:Pt:^Event:Qn


name: Microbiology - bacterial studies:Find:Pt:^Patient:Doc


name: Microbiology - parasitic studies:Find:Pt:^Patient:Doc


name: Donor contact information panel:-:Pt:^Donor:-


name: Has infectious disease or illness:Find:Pt:^Patient:Ord


name: Has valid driver license:Find:Pt:^Patient:Ord


name: PROMIS smoking - coping expectancies for all smokers - version 1.0 T-score


name: PROMIS smoking - emotional and sensory expectancies for all smokers - version 1.0 T-score


name: PROMIS smoking - emotional and sensory expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - negative health expectancies for all smokers - version 1.0 T-score


name: PROMIS smoking - negative health expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - negative psychosocial expectancies for all smokers - version 1.0 T-score


name: PROMIS smoking - negative psychosocial expectancies for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS smoking - nicotine dependence for all smokers - version 1.0 T-score


name: PROMIS smoking - nicotine dependence for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Residence renovation completion date:Date:Pt:^Patient:Qn


name: Residence renovation start date:Date:Pt:^Patient:Qn


name: Resident of region that is endemic for the disease of interest:Find:Pt:^Patient:Ord


name: Resident of region that is endemic for the disease of interest


name: STarT Back Screening Tool panel:-:Pt:^Patient:-:STarT Back


name: State where healthcare received outside resident state:Loc:Pt:^Patient:Nom


name: State where healthcare received outside resident state


name: PROMIS dyspnea severity - version 1.0 T-score


name: PROMIS dyspnea severity - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS item bank - dyspnea severity - version 1.0


name: Ambulatory blood pressure monitor study:Find:Pt:^Patient:Doc


name: Key words related to public health emergency:Find:Pt:^Event:Nom


name: Key words related to public health emergency


name: PhenX - body proportions protocol 220201:-:Pt:^Patient:-:PhenX


name: PhenX - body proportions protocol 220201


name: Heel-shin slide - left:Score:Pt:^Patient:Ord


name: Heel-shin slide - right:Score:Pt:^Patient:Ord


name: Response team name:ID:Pt:EMS response:Nom


name: Nonspecific intraventricular conduction delay


name: PROMIS item bank - dyspnea severity - version 1.0:-:7 days:^Patient:-:PROMIS


name: PROMIS item bank - mobility - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - mobility - version 2.0


name: PROMIS item bank - physical function - version 2.0


name: PROMIS item bank - physical function - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing daily activities - version 1.0


name: PROMIS item bank - self-efficacy for managing daily activities - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing emotions - version 1.0


name: PROMIS item bank - self-efficacy for managing emotions - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS parent proxy short form - meaning and purpose 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - meaning and purpose 8a - version 1.0 raw score


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - physical stress experiences 4a - version 1.0 raw score


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy short form - meaning and purpose 8a - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS short form - physical function 10a - version 2.0


name: PROMIS short form - physical function 10a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 10a - version 2.0 raw score


name: PROMIS short form - physical function 10b - version 2.0


name: PROMIS short form - physical function 10b - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - physical function 10b - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 10b - version 2.0 raw score


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS parent proxy strength impact - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy strength impact - version 1.0 T-score


name: PROMIS pediatric fatigue - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric fatigue - version 2.0 T-score


name: Substance with 4-hydroxyphenylpyruvate dioxygenase inhibitor mechanism of action (substance)


name: 4-hydroxyphenylpyruvate dioxygenase inhibitor (disposition)


name: Substance with interleukin 6 receptor antagonist mechanism of action (substance)


name: Interleukin 6 receptor antagonist (disposition)


name: Duke Treadmill Score panel:-:Pt:^Patient:-:DTS


name: Duke Treadmill Score risk level:Imp:Pt:^Patient:Ord:DTS


name: E Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little e Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: E Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: little e Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Rules for using smoked tobacco products inside home


name: Rules for using smoked tobacco products inside home:Find:Pt:^Patient:Nom


name: Rules for using smokeless tobacco products inside home


name: Rules for using smokeless tobacco products inside home:Find:Pt:^Patient:Nom


name: Physical security assessment system details


name: Physical security assessment system details:Find:Pt:^Event:Nar


name: Physical security assessment system name:Type:Pt:^Event:Nom


name: Physical security assessment system name


name: Physical security assessment system type


name: Physical security assessment system type:Type:Pt:^Event:Nom


name: PROMIS item bank - self-efficacy for managing medications and treatments - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing medications and treatments - version 1.0


name: PROMIS item bank - self-efficacy for managing social interactions - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing social interactions - version 1.0


name: PROMIS item bank - self-efficacy for managing symptoms - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - self-efficacy for managing symptoms - version 1.0


name: PROMIS item bank - smoking - coping expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - coping expectancies for all smokers - version 1.0


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0 raw score


name: PROMIS parent proxy short form - physical stress experiences 8a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PARENTPROXY


name: PROMIS pediatric anxiety - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric anxiety - version 2.0 T-score


name: PROMIS pediatric asthma impact - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric asthma impact - version 2.0 T-score


name: PROMIS pediatric depressive symptoms - version 2.0 T-score


name: PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: Lab observation result status:Type:Pt:^Patient:Nom


name: Lab order result status:Type:Pt:^Patient:Nom


name: ABCB1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Labor and delivery admission history and physical - recommended IHE set


name: Labor and delivery admission history and physical - recommended IHE set:-:Pt:{Setting}:-


name: Labor and delivery summary - recommended IHE set


name: Labor and delivery summary - recommended IHE set:-:Pt:{Setting}:-


name: PROMIS smoking - social motivations for all smokers - version 1.0 T-score


name: PROMIS smoking - social motivations for all smokers - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS upper extremity version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS upper extremity version 2.0 T-score


name: S Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little s Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: S Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: little s Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Scale for the Assessment and Rating of Ataxia


name: Physical therapy goal attainment expected duration - time frame:Time:Pt:^Patient:Qn


name: Physical therapy goal attainment expected duration - time frame


name: Physical therapy goal attainment expected duration - visits:Num:Pt:^Patient:Qn


name: Physical therapy goal attainment expected duration - visits


name: Physical therapy goals panel:-:Pt:^Patient:-


name: Physical therapy health concerns panel:-:Pt:^Patient:-


name: PROMIS item bank - smoking - emotional and sensory expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - negative health expectancies for all smokers - version 1.0


name: PROMIS item bank - smoking - negative health expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - negative psychosocial expectancies for all smokers - version 1.0


name: PROMIS item bank - smoking - negative psychosocial expectancies for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - nicotine dependence for all smokers - version v1.0


name: PROMIS item bank - smoking - nicotine dependence for all smokers - version v1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - social motivations for all smokers - version 1.0


name: PROMIS item bank - smoking - social motivations for all smokers - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - upper extremity - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - smoking - emotional and sensory expectancies for all smokers - version 1.0


name: PROMIS item bank - upper extremity - version 2.0


name: PROMIS pediatric depressive symptoms - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric item bank - anxiety - version 2.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - anxiety - version 2.0


name: PROMIS pediatric item bank - asthma impact - version 2.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - asthma impact - version 2.0


name: PROMIS pediatric item bank - depressive symptoms - version 2.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - depressive symptoms - version 2.0


name: PROMIS pediatric item bank - fatigue - version 2.0


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0


name: Information source for rumor related to public health emergency:Find:Pt:^Event:Nom


name: Number of residence renovations:Num:Pt:^Patient:Ord


name: Opioid risk tool panel:-:Pt:^Patient:-:ORT


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: Public health emergency budget source:Type:Pt:^Event:Nom


name: Portable medical order form:Find:Pt:{Setting}:Doc:{Role}


name: Physical therapy plan of care panel:-:Pt:^Patient:-


name: PROMIS mobility - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS parent proxy anxiety - version 2.0 T-score


name: PROMIS parent proxy anxiety - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy asthma impact - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy asthma impact - version 2.0 T-score


name: PROMIS parent proxy depressive symptoms - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy depressive symptoms - version 2.0 T-score


name: PROMIS parent proxy fatigue - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy fatigue - version 2.0 T-score


name: PROMIS pediatric item bank - fatigue - version 2.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - meaning and purpose - version 1.0


name: PROMIS pediatric item bank - meaning and purpose - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - pain behavior - version 1.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - pain behavior - version 1.0


name: PROMIS pediatric item bank - physical activity - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - physical activity - version 1.0


name: PROMIS pediatric item bank - physical stress experiences - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - physical stress experiences - version 1.0


name: PROMIS pediatric item bank - positive affect - version 1.0


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0


name: PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score


name: PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: {28 (ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack [Symdeko (50 MG / 75 MG; 75 MG)]


name: Substance with acetylserotonin-O-methyltransferase inhibitor mechanism of action (substance)


name: Glucagon-like peptide 2 receptor agonist (disposition)


name: Accuracy of information from source:Find:Pt:^Event:Ord


name: Action taken based on risk assessment meeting:Find:Pt:^Event:Nom


name: Action taken based on risk assessment meeting


name: Action taken based on watch record:Find:Pt:^Event:Nom


name: Biophysical agent plan to use:Prid:Pt:^Patient:Nom


name: Blood group Ag & Hemoglobin S inferred phenotype panel:-:Pt:Bld/Tiss^Donor:-:Molgen


name: Blood group Ag & Hemoglobin S inferred phenotype panel:-:Pt:Bld/Tiss:-:Molgen


name: Emergency operations center activation level


name: Emergency operations center activation level:Type:Pt:^Event:Ord


name: Finger chase - left:Score:Pt:^Patient:Ord


name: Finger chase - right:Score:Pt:^Patient:Ord


name: Cardiac drugs that increase blood pressure


name: Information communication technology description:Find:Pt:{Device}:Nom


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0


name: Source of population allelic frequency data


name: Time range until next menstrual period:Time:Pt:^Patient:Ord


name: PROMIS parent proxy item bank - anxiety - version 2.0


name: PROMIS parent proxy item bank - anxiety - version 2.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - asthma impact - version 2.0


name: PROMIS parent proxy item bank - asthma impact - version 2.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - depressive symptoms - version 2.0


name: PROMIS parent proxy item bank - depressive symptoms - version 2.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - meaning purpose - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - meaning purpose - version 1.0


name: PROMIS parent proxy item bank - pain behavior - version 1.0


name: PROMIS parent proxy item bank - pain behavior - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS pediatric item bank - psychological stress experiences - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric item bank - psychological stress experiences - version 1.0


name: PROMIS pediatric item bank - strength impact - version 1.0


name: PROMIS pediatric item bank - strength impact - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric meaning and purpose - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric meaning and purpose - version 1.0 T-score


name: PROMIS pediatric pain behavior - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric pain behavior - version 1.0 T-score


name: PROMIS pediatric physical activity - version 1.0 T-score


name: PROMIS pediatric physical activity - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric item bank - positive affect - version 1.0:-:Pt:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric physical stress experiences - version 1.0 T-score


name: Volunteer contact information panel:-:Pt:Volunteer:-


name: PROMIS parent proxy item bank - positive affect - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - positive affect - version 1.0


name: Substance with alkaline phosphatase inhibitor mechanism of action (substance)


name: Alkaline phosphatase inhibitor (disposition)


name: Substance with cytochrome P450 inhibitor mechanism of action (substance)


name: Interferon gamma inhibitor (disposition)


name: little c Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: C Ag inferred phenotype:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: little c Ag inferred phenotype:PrThr:Pt:Bld/Tiss^Donor:Ord:Molgen


name: Source of population allelic frequency data:Type:Pt:^Population:Nom


name: Treadmill angina:Presence or Identity:Duration of the study:^Patient:Nominal


name: PROMIS parent proxy item bank - physical activity - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - physical activity - version 1.0


name: PROMIS parent proxy item bank - physical stress experiences - version 1.0


name: PROMIS parent proxy item bank - physical stress experiences - version 1.0:-:7 days:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - psychological stress experiences - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - psychological stress experiences - version 1.0


name: PROMIS parent proxy item bank - strength impact - version 1.0:-:Pt:^Patient:-:PROMIS.PARENTPROXY


name: PROMIS parent proxy item bank - strength impact - version 1.0


name: PROMIS pediatric positive affect - version 1.0 T-score


name: PROMIS pediatric positive affect - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric psychological stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric psychological stress experiences - version 1.0 T-score


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0 raw score


name: PROMIS pediatric short form - depressive symptoms 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - pain behavior 8a - version 1.0:-:7 days:^Patient:-:PROMIS.PEDS


name: PROMIS pediatric short form - pain behavior 8a - version 1.0


name: PROMIS pediatric physical stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - pain behavior 8a - version 1.0 raw score


name: Age when first fed formula:Time:Pt:^Patient:Qn


name: Age when first fed something other than breast milk or formula


name: Age when first fed something other than breast milk or formula:Time:Pt:^Patient:Qn


name: Age when first injected non-prescription drug:Time:Pt:^Patient:Qn


name: Age when first injected non-prescription drug


name: Age when first used cocaine or crack:Time:Pt:^Patient:Qn


name: Intent of carbon monoxide exposure:Find:Pt:^Patient:Nom


name: Is your baby living with you:Find:Pt:^Patient:Ord


name: Emergency response improvement activity:Type:Pt:^Event:Nom


name: Emergency response plan objective:Find:Pt:^Event:Nom


name: Emergency response plan success analysis


name: Information communication technology description


name: Information communication technology name


name: Information communication technology name:ID:Pt:{Device}:Nom


name: Information communication technology type:Type:Pt:{Device}:Nom


name: Information communication technology type


name: Information source for rumor related to public health emergency


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score


name: PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score


name: PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0


name: Received healthcare in U.S. but outside resident state:Loc:Pt:^Patient:Nom


name: Received healthcare in U.S. but outside resident state


name: Reliability of information source:Find:Pt:^Event:Ord


name: Spinal muscular atrophy newborn screening comment-discussion


name: Spinal muscular atrophy newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Spinal muscular atrophy newborn screening panel


name: Spinal muscular atrophy newborn screening panel:-:Pt:Bld.dot:-


name: PROMIS pediatric short form - pain behavior 8a - version 1.0 raw score:Score:7 days:^Patient:Quantitative:PROMIS.PEDS


name: PROMIS pediatric strength impact - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric strength impact - version 1.0 T-score


name: PROMIS physical function - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS physical function - version 2.0 T-score


name: PROMIS self-efficacy for managing emotions - version 1.0 T-score


name: PROMIS self-efficacy for managing emotions - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS self-efficacy for managing medications and treatments - version 1.0 T-score


name: PROMIS self-efficacy for managing medications and treatments - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: Alpha1 proteinase inhibitor (disposition)


name: Age when first used heroin:Time:Pt:^Patient:Qn


name: Age when first used marijuana:Time:Pt:^Patient:Qn


name: Age when stopped smoking cigarettes completely


name: Age when stopped smoking cigarettes completely:Time:Pt:^Patient:Qn


name: Discharged from the U.S. Armed Forces:Find:Pt:^Patient:Ord


name: PROMIS parent proxy meaning purpose - version 1.0 T-score


name: PROMIS parent proxy pain behavior - version 1.0 T-score


name: PROMIS parent proxy pain behavior - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy physical activity - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy physical activity - version 1.0 T-score


name: PROMIS parent proxy physical stress experiences - version 1.0 T-score


name: PROMIS parent proxy physical stress experiences - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy meaning purpose - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4


name: prothrombin activity actual/normal in platelet poor plasma by coagulation assay (lab test)


name: {1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack


name: Post-discharge provider name in Provider


name: unidentified cells/100 leukocytes in cerebral spinal fluid by manual count (lab test)


name: HIV reverse transcriptase susceptibility panel by Genotype method (lab test)


name: mononuclear cells/100 leukocytes in cerebral spinal fluid (lab test)


name: PAIN SENSITIVITY QUANTITATIVE TRAIT LOCUS 1


name: Unique bar code number of Initial sample


name: Sample quality of Dried blood spot (lab test)


name: mesothelial cells/100 leukocytes in cerebral spinal fluid (lab test)


name: Noninvasive prenatal fetal 18 and 21 aneuploidy panel, Plasma cell-free DNA by Sequencing


name: Bilateral bidirectional superior cavopulmonary anastomoses


name: HIV nonnucleoside reverse transcriptase susceptibility panel by Genotype method (lab test)


name: HIV nucleoside reverse transcriptase susceptibility panel by Genotype method (lab test)


name: Specific gravity of Urine by Automated test strip (lab test)


name: Serotonin receptor agonist (disposition)


name: Cross-Linking and Immunoprecipitation Followed by Deep Sequencing


name: Sphingosine 1 Phosphate Receptor Modulators


name: Amputation of bilateral feet (procedure)


name: Dihydrofolate reductase inhibitor (disposition)


name: mononuclear cells/100 leukocytes in cerebral spinal fluid by manual count


name: Blood gas analyses base excess in capillary blood by calculation


name: mesothelial cells/100 leukocytes in cerebral spinal fluid by manual count


name: Eosinophils/100 leukocytes in Urine sediment by Manual count


name: Views + Danelius Miller:Find:Pt:Lower extremity>Hip:Doc:XR


name: Transnasal humidified rapid-insufflation ventilatory exchange


name: I have trouble concentrating in the past 7D


name: Days in therapeutic INR range/Days INR result determined


name: Lidocaine Hydrochloride;Cream, Multi Ingredient 5%; NA Topical application Kit


name: {5 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 7.1 - 7.5 kg]


name: {8 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 11.6 - 12.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 7 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 11.1 - 11.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 6 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 10.6 - 11.0 kg]


name: {7 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 10.1 - 10.5 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 6 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 9.6 - 10.0 kg]


name: {9 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 13.1 - 13.5 kg]


name: {2 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 2.6 - 3.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 2 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 4.6 - 5.0 kg]


name: {3 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 4.1 - 4.5 kg]


name: Human reference sequence assembly version


name: Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel, Plasma cell-free DNA by Sequencing


name: HIV protease gene mutations by Genotype method (lab test)


name: HIV protease gene mutations by Phenotype method


name: HIV susceptibility panel by Genotype method (lab test)


name: microdeletion syndromes in blood or tissue by FISH


name: {28 (alpelisib 200 MG Oral Tablet [Piqray]) } Pack [Piqray 200 MG Daily Dose]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 8 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 12.6 - 13.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 4 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 6.6 - 7.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 3 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 6.1 - 6.5 kg]


name: {4 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 5.6 - 6.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 3 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 5.1 - 5.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 5 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 9.1 - 9.5 kg]


name: {6 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 8.6 - 9.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 5 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 8.1 - 8.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 4 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 7.6 - 8.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 7 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 12.1 - 12.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 1 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 3.1 - 3.5 kg]


name: {56 (alpelisib 150 MG Oral Tablet [Piqray]) } Pack [Piqray 300 MG Daily Dose]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 2 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 3.6 - 4.0 kg]


name: Lower oesophageal sphincter magnetic augmentation


name: Patent ductus arteriosus stent placement


name: Nuclear magnetic resonance imaging pancreas


name: Post vaccination challenge strain shedding


name: International cooperative ataxia rating scale


name: Immature granulocyte percentage increased


name: Misleading serological test result by vaccination


name: Misleading serological test result by passive antibody transfer


name: Therapeutic tumor infiltrating lymphocytes (procedure)


name: Anti-RNA polymerase III antibody increased


name: Anti-RNA polymerase III antibody negative


name: Anti-RNA polymerase III antibody positive


name: Pulmonary artery oxygen saturation decreased


name: Forced expiratory volume/forced vital capacity ratio decreased


name: Magnetic resonance proton density fat fraction measurement


name: Device inappropriate antitachycardia pacing


name: Amyloid related imaging abnormality-haemorrhages


name: Amyloid related imaging abnormality-haemosiderin deposits


name: Amyloid related imaging abnormality-superficial siderosis


name: coagulation factor X activity actual/normal in platelet poor plasma by chromogenic method


name: Clinical Proteomic Tumor Analysis Consortium


name: CDISC SEND Rad/Nuc Agent Source Response Terminology


name: Radiological/Nuclear Challenge Agent Source Type


name: CDISC SEND Biological Challenge Agent Category Response Terminology


name: Fractional oxyhemoglobin in Arterial blood (lab test)


name: HIV integrase inhibitor susceptibility panel by Genotype method (lab test)


name: HIV integrase inhibitor susceptibility panel by Phenotype method (lab test)


name: {39 (dexamethasone 1.5 MG Oral Tablet) } Pack [Dxevo 11 Day Taper]


name: {9 (cladribine 10 MG Oral Tablet) } Pack


name: {8 (cladribine 10 MG Oral Tablet) } Pack


name: {8 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 8 Tablet Pack]


name: {7 (cladribine 10 MG Oral Tablet) } Pack


name: {7 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 7 Tablet Pack]


name: {6 (cladribine 10 MG Oral Tablet) } Pack


name: {6 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 6 Tablet Pack]


name: {5 (cladribine 10 MG Oral Tablet) } Pack


name: {5 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 5 Tablet Pack]


name: {4 (cladribine 10 MG Oral Tablet) } Pack


name: {4 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 4 Tablet Pack]


name: {2 (cladribine 10 MG Oral Tablet) } Pack


name: {2 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 2 Tablet Pack]


name: CDISC SEND Study Report Status Response Terminology


name: {10 (cladribine 10 MG Oral Tablet) } Pack


name: {10 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 10 Tablet Pack]


name: {12 (siponimod 0.25 MG Oral Tablet) } Pack


name: {2 (0.83 ML risankizumab-rzaa 90.4 MG/ML Prefilled Syringe [Skyrizi]) } Pack [Skyrizi 150 MG Dose Syringe Pack]


name: {2 (thyrotropin alfa 1.1 MG Injection) } Pack


name: patient location - EntityInformationSensitivityPolicy


name: Compression Therapy for Neuropathy Prevention


name: Challenge Agent Treatment Efficacy Study


name: Radiological/Nuclear Agent Ionizing Radiation Type


name: CDISC SEND Rad/Nuc Agent Ionizing Radiation Type Response Terminology


name: Cladribine 10 MG Oral Tablet [Mavenclad], Includes the 4, 5, 6, 7, 8, 9 & Mavenclad 10 Tablet Pack


name: CDISC SEND Challenge Agent Category Response Terminology


name: Threonine to Creatinine Ratio Measurement


name: Hemoglobin H Inclusion Bodies Measurement


name: Questionnaire Not Completed Due to Patient Illness


name: Trisomy 18 risk cutoff in Fetus (lab test)


name: Unique bar code number of Current sample


name: Beta lactamase organism identified in Isolate


name: rnax perform urinary catheter care (treatment)


name: {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]) } Pack [Evenity 210 MG Dose]


name: protirelin 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 33.18 g in 177 mL TOPICAL LOTION [365 Everyday Value]


name: ZINC OXIDE 8.25 g in 44 mL TOPICAL LOTION [365 Everyday Value]


name: Florfenicol 1 g in 1 g NOT APPLICABLE POWDER


name: cholesterol 1 gram-28 kcal/10 gram ORAL POWDER (GRAM)


name: almond oil/silicon,colloidal/butylated hydroxytoluene ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: gelatin sponge,absorbable TOPICAL SYRINGE (EA)


name: ENSULIZOLE 3 g in 100 mL TOPICAL LIQUID [FULL SPECTRUM MATTE AMBITION SKIN PRIMER SPF 20]


name: {21 (dexamethasone 1.5 MG Oral Tablet) } Pack [HiDex 6-Day Taper]


name: {27 (dexamethasone 1.5 MG Oral Tablet) } Pack [TaperDex 7-Day Taper]


name: BAG,BEDSIDE,MOVEEN 2000ML COLOPLAST #21346


name: BANDAGE TUBULAR ELASTIC 4.5IN X 11YD GLG10


name: TUBE FEEDING SET,EXTENSION ENFIT#0141-24


name: DRESSING,PURACOL PLUS 1IN X 8IN MSC861X8


name: DRESSING,AQUACEL AG SURGICAL 9CM X 25CM C#412011


name: Avobenzone/Octisalate/Octocrylene 3%-2%-10% Topical application Lotion [Gold Bond Men's Essentials 5in1 Face]


name: Solox Gel Silver Antimicrobial Topical Wound Gel


name: Accu-Chek Aviva Plus Blood Glucose Meter Kit


name: Gel, Multi Ingredient Topical application Gel/Jelly [Collatyl]


name: SPOTLESS REGIMEN FOR ACNE, BLEMISHES AND BREAKOUTS KIT


name: TITANIUM DIOXIDE 0.03 g in 1 mL / ZINC OXIDE 0.14 g in 1 mL TOPICAL LOTION [UNBLEMISH Shine Free]


name: zinc oxide 7 g in 100.0 mL / TITANIUM DIOXIDE 3 g in 100.0 mL TOPICAL CREAM [DermaDoctor DD Eye SPF30]


name: GoodSense 3-Bevel 31G 3/16 inch Pen Needle


name: GoodSense 3-Bevel 31G 5/16 inch Pen Needle


name: GoodSense 3-Bevel 32G 1/4 inch Pen Needle


name: GoodSense 3-Bevel 32G 5/32 inch Pen Needle


name: GoodSense 31G 3/16 inch Safety Pen Needle


name: Nutricia KetoCal 2.5:1 Enteral Suspension (Vanilla)


name: Hypochlorous Acid 0.0085% Topical application Gel/Jelly [Zenoptiq]


name: Lubricant Topical application Gel/Jelly [Aqua Lube Natural]


name: Medical Food Oral Powder for Suspension [TYR Sphere 20]


name: Oatmeal, Gum Fraction 1% Topical application Cream [Eczema Relief]


name: Hypochlorous Acid 0.0085% Topical application Gel/Jelly


name: Hypochlorous Acid 0.012% Topical application Solution


name: Placental Tissue Human Topical application Sheet


name: Topi-Click Micro 9mL Disposable Topical Applicator (Blue/Pin Point)


name: Topi-Click Micro 9mL Disposable Topical Applicator (Blue/Rounded)


name: Topi-Click Micro 9mL Disposable Topical Applicator (Blue/Soft Angled)


name: Hypochlorous Acid 0.01% Topical application Solution [Zenoptiq]


name: {3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack


name: {3 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 84 MG Dose Kit]


name: {2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray) } Pack


name: {2 (0.2 ML) (esketamine 140 MG/ML Nasal Spray [Spravato]) } Pack [Spravato 56 MG Dose Kit]


name: {1 (chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Solution) } Pack


name: AMINOPENTAMIDE SULFATE 1 g in 1 g NOT APPLICABLE POWDER


name: Adenosine 0.02 g in 50 mL TOPICAL CREAM [CONJU Princess Lifting]


name: DOXYCYCLINE 1 kg in 1 kg NOT APPLICABLE POWDER


name: TOCERANIB PHOSPHATE 1 g in 1 g NOT APPLICABLE POWDER


name: TRIMEPRAZINE TARTRATE 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 220 mg in 1 mL TOPICAL OIL [ACTIVE ARGAN 365 SPF 30 BROAD SPECTRUM ACTIVATED ARGAN COMPLEX]


name: Adenosine 0.01 g in 25 mL TOPICAL PATCH [CONGJU PRINCESS LIFTING MASK SHEET]


name: Dimethicone 2.5 g in 50 mL TOPICAL GEL [CONJU PRINCESS MOISTURE]


name: Dimethicone 3.6 g in 120 mL TOPICAL LIQUID [CONJU PRINCESS RICH ESSENCE]


name: Mineral Oil 72.27 g in 100 mL TOPICAL GEL [CONJU PRINCESS CLEANSING BALM]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [CONGJU PRINCESS EYE AND NECK]


name: DIETHYLSTILBESTROL 1 g in 1 g NOT APPLICABLE POWDER


name: Niacinamide 0.6 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM]


name: Niacinamide 0.6 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT PEPTIDE SERUM]


name: Niacinamide 0.6 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT HYALURONIC SERUM]


name: Niacinamide 0.6 g in 30 mL / Adenosine 0.012 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT 24K GOLD SERUM]


name: Niacinamide 0.6 g in 30 mL / Adenosine 0.012 g in 30 mL TOPICAL LIQUID [LEBODY LAB RENEWAL DUAL EFFECT BTX COLLAGEN SERUM]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [Lilikoi Mineral Defense Sport Sunscreen SPF 30]


name: Compound HIPAA Research Authorization and Informed Consent for Research


name: jurisdictional specified controlled unclassified information policy


name: personal non-sensitive information policy


name: personal limited data set information policy


name: personal de-identified information policy


name: organizational uncontrolled unclassified information policy


name: organizational specified controlled unclassified information policy


name: organizational public information policy


name: organizational non-sensitive information policy


name: organizational limited data set information policy


name: organizational de-identified informati)on policy


name: organizational basic controlled unclassified information policy


name: jurisdictional uncontrolled unclassified information policy


name: jurisdictional public information policy


name: jurisdictional non-sensitive information policy


name: jurisdictional de-identified information policy


name: jurisdictional controlled unclassified information policy


name: Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes


name: HIPAA Authorization for Disclosure for Research Consent Directive


name: opt-out of personal information or effect sharing via a registry or repository


name: opt-out of personal information or effect collection in a registry or repository


name: opt-in to personal information or effect sharing via a registry or repository


name: opt-in to personal information or effect collection in a registry or repository


name: Foundational Model of Anatomy Ontology, 4_15


name: CPTAC Environmental/Occupational Exposure Codelist


name: Specify Site if Documented Distant Metastasis


name: Specify Type of Testing and Results if Yes


name: High Sensitivity C-Reactive Protein Measurement


name: Was Additional Testing Performed Question


name: Number of Lymph Nodes Positive for Tumor by IHC Staining Only


name: Number of Lymph Nodes Positive for Tumor by H&E


name: Therapeutic Ionizing Radiation to Head History Question


name: Was Adjuvant I-131 Therapy Administered Question


name: Androgen Receptor Status by Immunochemistry


name: Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium


name: Viral Envelope Glycoprotein Purification


name: Referral Made Based on This Score Question


name: Referral Made Based on Final Score Question


name: What is the First Presenting Symptom Related to Disease


name: Temporally-Feathered Intensity-Modulated Radiation Therapy


name: Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells


name: Use Phone Less Often than Would Like Due to Hearing Problem Question


name: Avoid Groups of People Due to Hearing Problem Question


name: Irritable Due to Hearing Problem Question


name: Difficulty Attending Party Due to Hearing Problem Question


name: Feel Stupid or Dumb Due to Hearing Problem Question


name: Visit People Less Often than Like Due to Hearing Problem Question


name: Go Shopping Less Often than Like Due to Hearing Problem Question


name: Upset by Problem or Difficulty with Hearing Question


name: Want to be Alone Due to Hearing Problem Question


name: Talk to Family Members Less Often than Like Due to Hearing Problem Question


name: Feel Depressed Due to Hearing Problem Question


name: Listen to TV or Radio Less Often than Like Due to Hearing Problem Question


name: Feel Uncomfortable when Talking with Friends Due to Hearing Problem Question


name: Feel Left Out When with a Group of Friends Due to Hearing Problem Question


name: Difficulty Hearing or Understanding Co-workers, Clients, or Customers Due to Hearing Problem Question


name: Difficulty in Movies or Theater Due to Hearing Problem Question


name: Multi-detector Computed Tomography Angiography


name: Civilian Health and Medical Program of the Department of Veterans Affairs


name: Neoplastic Plasma Cells 30 Percent or More of Bone Marrow Nucleated Cells


name: Hearing Handicap Inventory Screening Questionnaire for Adults


name: Did Patient Follow Through with Referral Question


name: BCR-JAK2 Fusion in Hematologic Malignancies


name: Testosterone Greater than or Equal to 200 ng/dL


name: What is the Hormonal Contraceptive Use Status


name: Performance Status Scale Timing Not Evaluated


name: Age When Started using Smokeless Tobacco after Regular Use Question


name: International Normalized Ratio of Prothrombin Time Level Finding


name: First Degree Family History of Cancer Question


name: First Degree Family History of Esophageal or Gastric Esophageal Cancer


name: Is there a First Degree Family History of Primary Brain Tumor Question


name: Is there a First Degree Family History of Thyroid Cancer Question


name: Boston University-Boston Medical Center Cancer Center


name: Brown University Oncology Research Group


name: How Often Took Retroviral Agents Past 6 Months Question


name: Fluorine F 18-Active Site Inhibited Factor VIIa


name: Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents


name: Nanoscale Coordination Polymer Nanoparticles CPI-100


name: CPTAC Bladder Urothelial Carcinoma Baseline Form


name: CPTAC Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma Baseline Form


name: CPTAC Esophageal Carcinoma Baseline Form


name: CPTAC Liver Hepatocellular Carcinoma Baseline Form


name: CPTAC Prostate Adenocarcinoma Baseline Form


name: CPTAC Stomach Adenocarcinoma Baseline Form


name: Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate


name: Emtricitabine/ Tenofovir Alafenamide Fumarate


name: Emtricitabine/ Rilpivirine/ Tenofovir Alafenamide Fumarate


name: Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid


name: Other and Unspecified Events of Undetermined Intent and their Sequelae


name: Symptoms, Signs and Abnormal Clinical and Laboratory Findings, NEC


name: Illness is Financial Hardship for My Family and Me Question


name: Blasts 0.01 Percent or More of Bone Marrow Nucleated Cells


name: Pediatric Quality of Life Brain Tumor Module Version 1.0


name: Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present


name: Intra or Intercytoplasmic Lumina Present


name: CDISC Questionnaire PHQ-2 Test Name Terminology


name: CDISC Questionnaire PHQ-2 Test Code Terminology


name: PHQ-2 - Little Interest or Pleasure in Doing Things


name: PHQ-2 - Feeling Down, Depressed or Hopeless


name: Maraba Oncolytic Virus Expressing Mutant HPV E6/E7


name: Behavioral Measures For Treating Sleep Disordered Breathing


name: Cognitive behavioral therapy for insomnia


name: Glioma, Glioblastoma & Astrocytoma Surgery


name: Intestinal Rehabilitation and Transplant


name: Lower Gastrointestinal Therapeutic Surgical Procedure


name: Minimally Invasive Joint Replacement Surgery


name: Physical Therapy for Orthopedics and Sports Medicine


name: Scoliosis and Kyphosis Deformity Correction


name: Subfascial Endoscopic Perforator Surgery


name: Therapeutic Upper Gastrointestinal Procedures


name: Transthoracic Myocardial Laser Revascularization


name: Neoplastic Plasma Cells 20 Percent or More of Peripheral Blood White Cells


name: Lymphoma Cells More than 25 Percent of Bone Marrow Nucleated Cells


name: Is Any Metastatic Diagnosis Present Question


name: Recombinant Bovine Basic Fibroblast Growth Factor


name: Protein Arginine Methyltransferase 5 Inhibitor PF-06939999


name: Dihydroorotate Dehydrogenase Inhibitor AG-636


name: CDISC ADaM Geriatric Depression Scale Short Form Questionnaire Parameter Code Terminology


name: CDISC ADaM Geriatric Depression Scale Short Form Questionnaire Parameter Name Terminology


name: CDISC SEND Challenge Agent Parameter Code Terminology


name: CDISC SEND Challenge Agent Parameter Long Name Terminology


name: CDISC SEND Age Estimation Method Response Terminology


name: CDISC SEND Restraint Mode Response Terminology


name: CDISC SEND Sexual Maturity Status Response Terminology


name: Transplant Registry Unified Management Program


name: 7 Lead Placement Standard for Non-Human Subjects


name: Extended Release Capsule, Hard Dosage Form


name: Extended Release Capsule, Softgel Dosage Form


name: Monoclonal Protein Spike Region Identification


name: Soluble Interleukin 2 Receptor Measurement


name: Direct Bilirubin to Bilirubin Ratio Measurement


name: Glycated Albumin to Albumin Ratio Measurement


name: Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement


name: Sezary Cells to Leukocytes Ratio Measurement


name: Fluorescent Antibody Virus Neutralization Assay


name: Multiplex Real-time Polymerase Chain Reaction Assay


name: N-acetylaspartate and N-acetyl-aspartylglutamate Measurement


name: Free Choline and Glycerophosphorylcholine and Phosphorylcholine Measurement


name: Creatine and Phosphocreatine Measurement


name: Glycerophosphorylcholine and Phosphorylcholine Measurement


name: IRANO Okada 2015 Oncology Response Criteria


name: Volume of Distribution Observed for Unbound Drug


name: Volume of Distribution Predicted for Unbound Drug


name: Volume of Distribution of Fraction Dose Predicted Corrected for Unbound Drug


name: Estimated Next Menstrual Period Start Date


name: Multiple Challenge Agent Different Category Indicator


name: Multiple Challenge Agent Same Category Indicator


name: Biological Agent Certificate of Analysis Indicator


name: Biological Challenge Agent Scientific Name


name: Master Bank or Seed Stock Immediate Supplier


name: Biological Agent Nucleotide Sequence Indicator


name: Biological Agent Nucleotide Sequence Location


name: Working Bank or Primary Stock Characterized Indicator


name: Challenge Agent Metabolite Caused Injury Indicator


name: Radiological/Nuclear Agent Irradiation Source Beam Strength


name: Challenge Agent Type Mixed Field Indicator


name: Major Histocompatibility Complex Tested Indicator


name: Efficacy Study With Pre-Exposure Prophylaxis


name: Efficacy Study With Post-Exposure Prophylaxis


name: Efficacy Study With Post-Exposure Radiomitigation


name: Antimicrobial or Acidified/Chlorinated Water During Husbandry Indicator


name: Challenge Agent Multiple Route Indicator


name: Factor for Toxicological Dose Descriptor


name: Marked Thickening of the Bladder Urothelium Present


name: High-Dose-Rate Vaginal Cuff Brachytherapy


name: Low-Dose-Rate Vaginal Cuff Brachytherapy


name: Months Since Completion of Primary Therapy


name: Physician's Global Assessment Scale of Epidermal Chronic Graft versus Host Disease


name: Green Tea/Licorice Extract-based Antioxidant Solution


name: Whey Protein Isolate-based Nutritional Supplement


name: Barrett Esophagus With Metaplastic Non-Goblet Cell Columnar Epithelium


name: Questionnaire Not Completed Due to Institutional Error


name: CPTAC Brain Lower Grade Glioma Baseline Form


name: NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor


name: Aspartate Aminotransferase to Creatine Kinase Ratio Measurement


name: RANO Ellingson 2017 Oncology Response Criteria


name: Transcribe Data into CDR and Record the Following


name: Recombinant human glutamic acid decarboxylase


name: ZONISAMIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ETHAMBUTOL HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 200 ug in 1 g TOPICAL STICK [Thinksport Sunscreen SPF 30]


name: DIETHYLTOLUAMIDE 10 g in 100 mL TOPICAL LIQUID [MOSQUITO BUG OFF]


name: HOMOSALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / ZINC OXIDE 150 mg in 1 g TOPICAL STICK [Equate Sunscreen Mineral Based KIDS Broad Spectrum spf 50]


name: Titanium Dioxide 1.63 g in 15 g / Octinoxate 1.05 g in 15 g / Octisalate 0.45 g in 15 g TOPICAL POWDER [GALAXYBORN SATIN CUSHION NO 23]


name: Titanium Dioxide 1.70 g in 15 g / Octinoxate 1.05 g in 15 g / Octisalate 0.45 g in 15 g TOPICAL POWDER [GALAXYBORN SATIN CUSHION NO 21]


name: Pro Comfort Adult Inhaler Spacer Chamber


name: Pro Comfort Child Inhaler Spacer Chamber


name: EnovaRX - Cyclobenzaprine Hydrochloride 2% in Microderm External Cream Compounding Kit


name: EnovaRX - Diclofenac Sodium 2.5% in Microderm External Cream Compounding Kit


name: Collagen, Bovine/Silver Oxide 1% Topical application Gel/Jelly


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [EQUATE Sunscreen SPORT Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Equate-Sunscreen Broad Spectrum SPF 50 ULTRA]


name: ENSULIZOLE 3 g in 100 mL TOPICAL LIQUID [Covergirl TruBlend Base Business Everyday Defense Primer SPF 20]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [EQUATE Sunscreen BABY Broad Spectrum SPF 50]


name: Maltodextrin/Starch, Corn Oral Powder [Thick & Easy]


name: Electrolytes Oral Solution [Leader Electrolyte]


name: Ointment, Multi Ingredient Topical application Ointment [Lip Care]


name: OMEPRAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: {39 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: TRACH STOMA PROTECTOR,FOAM 2IN X 2.5IN LUMINAUD #63024


name: TRACH TUBE,SZ 7.5 BIVONA TTS SMITHS #670175


name: CATHERIZATION SET,FOLEY W/O CATH RELIAMED #ZRCIT10CC


name: CATHETER,FOLEY SILICONE DOVER 16FR 5ML COVIDIEN #605163IC


name: CATHETER,SUCTION,12FR KIT CARDINAL HEALTH #ZRSCK12


name: SET,INFUSION AUTOSOFT XC TANDEM #1001683


name: KIT PREP OF TECHNETUM TC-99 EXAMETAZIME INJ


name: KIT PREP OF TECHNETUM TC-99 MEBROFENIN INJ


name: Silicone Topical application Gel/Jelly [ScarSilk Gel]


name: camphor / lidocaine / menthol / methyl salicylate


name: DOXYCYCLINE HYCLATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: OCTINOXATE 72 mg in 1 mL / TITANIUM DIOXIDE 26.736 mg in 1 mL TOPICAL CREAM [ACTIBEAU Camellia Floral Calming Sunscreen]


name: ZINC OXIDE 109.52 mg in 1 mL / TITANIUM DIOXIDE 48.187 mg in 1 mL TOPICAL CREAM [ACTIBEAU Camellia Natural Mineral UV Defense Sunscreen]


name: CARBAZOCHROME 1 g in 1 g NOT APPLICABLE POWDER


name: multivitamin with minerals combination no.65


name: water for injection (PEG-400, NADA, lysine)


name: lancing device, vacuum/lancets MISCELL COMBINATION PACKAGE (EA)


name: emollient combination no.112 TOPICAL CREAM (GRAM)


name: emollient combination no.113 TOPICAL CREAM (GRAM)


name: lollipop base no.232 MISCELL POWDER (GRAM)


name: suppository base no.231 MISCELL PELLET (GRAM)


name: suppository base no.234 MISCELL PELLET (GRAM)


name: urinary bag/catheter 12 Fr-8" MISCELL COMBINATION PACKAGE (EA)


name: lollipop base no.233 MISCELL POWDER (GRAM)


name: ALLANTOIN 0.05 g in 100 g TOPICAL LIQUID [Kenaf wet wipe kids]


name: ADENOSINE 0.04 g in 100 mL / NIACINAMIDE 2 g in 100 mL TOPICAL LOTION [BOTANIC TWENTY RECHARGING]


name: ADENOSINE 0.04 g in 150 mL / NIACINAMIDE 2 g in 150 mL TOPICAL CREAM [BOTANIC TWENTY HYPERCARE NOURISHING]


name: ADENOSINE 0.04 g in 50 mL / NIACINAMIDE 2 g in 50 mL TOPICAL CREAM [BOTANIC TWENTY LIGHT WATERY]


name: {9 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 9 Tablet Pack]


name: DIMETHICONE 4 mg in 1 mL TOPICAL CREAM [AFTER CARE]


name: ERYTHROMYCIN ETHYLSUCCINATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: HOMOSALATE 10 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL CREAM [3-in-1 Face Moisturizer Broad Spectrum SPF 20]


name: almond oil/silicic acid/butylated hydroxytoluene ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: hypochlorous,hydrochlor acid/sodhypochlor/sodmagfluo/e.water 0.0085 % TOPICAL GEL WITH PUMP (ML)


name: sodium/chloride/citrate 50 mEq-20 mEq-30 mEq ORAL POWDER IN PACKET (EA)


name: thiamine mononitrate (vit B1) 90 mg/scoop ORAL POWDER (GRAM)


name: ZINC OXIDE 60 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [JACKET SPF-50 Broad Spectrum Sunscreen]


name: {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe) } Pack


name: Miconazole Nitrate/Terbinafine Hydrochloride 2%-2.5% Topical application Solution


name: {12 (siponimod 0.25 MG Oral Tablet [Mayzent]) } Pack [Mayzent 2 MG Starter Pack]


name: Niacinamide 1.60 g in 80 mL / Adenosine 0.03 g in 80 mL TOPICAL SPRAY [RUBELLI WATER GLOW ESSENCE 80mL]


name: Camphor/Lidocaine/Methyl Salicylate;Diclofenac Sodium 2%-2.5%-4%; 1.5% Topical application Kit


name: Niacinamide 0.60 g in 30 g / Adenosine 0.01 g in 30 g TOPICAL CREAM [INCELLDERM Cocktail Aqua BB]


name: Niacinamide 0.75 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [INCELLDERM ACTIVE]


name: Niacinamide 1.00 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL SPRAY [INCELLDERM Vallatto Oi l Mist]


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Russian Edition


name: GoodSense 6-Bevel 32G 5/32 inch Pen Needle


name: GoodSense 6-Bevel 31G 3/16 inch Pen Needle


name: Accu-Chek Guide Me Blood Glucose Monitor Kit


name: Eyelid Cleanser Topical application Pad [Systane Lid Wipes]


name: Nicotinamide Riboside Chloride Bulk powder


name: Articaine Hydrochloride and Epinephrine Bitartrate


name: Contour Next One Monitor Syst by Ascencia


name: Contour Next Glucose Test Strips by Ascensia


name: Contour Next EZ Monitor Syst by Ascensia


name: Contour Monitor Syst, Simple Pk by Ascensia


name: Contour Blood Glucose Test Strips by Ascensia


name: Lotion, Multi Ingredient Topical application Lotion [Daily Moisturizing Lotion]


name: Cream, Multi Ingredient Topical application Cream [Moisturizing Cream]


name: Valbenazine;Valbenazine 40 MG; 80 MG Oral Capsule


name: LAPATINIB 1 g in 1 g NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 24 g in 100 mL TOPICAL LOTION [Play Mineral Broad Spectrum SPF 50]


name: ETHYLHEXYL TRIAZONE 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 50 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / ECAMSULE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / BEMOTRIZINOL 40 mg in 1 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 30 mg in 1 mL TOPICAL LOTION [Kiehls Activated Sun Protector Sunscreen SPF 30 For Face and Body For All Skin Types]


name: DROMETRIZOLE TRISILOXANE 40 mg in 1 mL / ECAMSULE 120 mg in 1 mL / BEMOTRIZINOL 5 mg in 1 mL / TITANIUM DIOXIDE 40 mg in 1 mL / OCTINOXATE 67.5 mg in 1 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 5 mg in 1 mL TOPICAL CREAM [Kiehls Ultra Light Daily UV Defense CC SPF 50 Anti Pollution]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 2.75 g in 100 mL / OXYBENZONE 2 g in 100 mL TOPICAL SPRAY [ALOE UP PRO 30 CONTINUOUS SUNSCREEN]


name: OCTINOXATE 7.4 g in 100 g / HOMOSALATE 14.5 g in 100 g / OXYBENZONE 5.9 g in 100 g TOPICAL CREAM [ALOE KOTE SPF 25]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 2.75 g in 100 mL / OXYBENZONE 4 g in 100 mL TOPICAL SPRAY [ALOE UP PRO 50 CONTINUOUS SUNSCREEN]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 2.5 g in 100 g / OXYBENZONE 6 g in 100 g TOPICAL LIPSTICK [ALOE UP MEDICATED LIP BALM SPF 30]


name: SIROLIMUS 1 g in 1 g NOT APPLICABLE POWDER


name: DACTINOMYCIN 1 g in 1 g NOT APPLICABLE POWDER


name: Octocrylene/Zinc Oxide 4%-9.7% Topical application Lotion [Blue Lizard Sport]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 5 g in 100 mL TOPICAL LOTION [MURAD - ACNE CONTROL - oil AND PORE CONTROL MATTIFIER SPF-45]


name: PERMETHRIN 0.5%/PIPERONYL BUTOXIDE 4%/PYRETHRINS 0.33% KIT


name: ASPARAGINASE 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 20 mg in 1 mL TOPICAL LOTION [Sun Guard]


name: Niacinamide 1.30 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [PAPA RECIPE EGGPLANT CLEARING]


name: Niacinamide 0.5 g in 25 g TOPICAL PATCH [PAPA RECIPE BOMBEE BRIGHTENING HONEY MASK PACK]


name: Adenosine 0.012 g in 30 mL TOPICAL LIQUID [MUSTUS NONI AMPOULE]


name: Octinoxate 3.50 g in 50 mL / Homosalate 1.50 g in 50 mL / Octisalate 1.50 g in 50 mL / Titanium Dioxide 0.74 g in 50 mL TOPICAL CREAM [PAPA RECIPE HONEY MOIST SUN ESSENCE]


name: GLYCERIN 1.131 g in 25 mL / Allantoin 0.025 g in 25 mL TOPICAL LIQUID [Ashwagandha Ferment Mask]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [BEAST HYDRATING FACE SPF-20]


name: Adenosine 0.008 g in 20 g TOPICAL PATCH [MUSTUS DAILY HARVEST SQUEEZE LIFT UP MASK PACK]


name: Niacinamide 0.4 g in 20 g TOPICAL PATCH [MUSTUS DAILY HARVEST SQUEEZE TONE UP MASK PACK]


name: METRONIDAZOLE BENZOATE 1 g in 1 g NOT APPLICABLE POWDER


name: CLARITHROMYCIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: frida mom Postpartum Recovery Essentials KIT


name: frida mom Labor and Delivery Plus Postpartum Recovery KIT


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL STICK [Softlips Oasis Watermelon Blackberry]


name: Niacinamide 0.48 g in 24 mL / Adenosine 0.009 g in 24 mL TOPICAL PATCH [HI HANJI]


name: ZINC OXIDE 250 mg in 1 g TOPICAL CREAM [Earth Mama Baby Mineral Sunscreen SPF 40]


name: ZINC OXIDE 220 mg in 1 g TOPICAL CREAM [Earth Mama Baby Face Mineral Sunscreen SPF 40]


name: Octocrylene/Zinc Oxide 4%-9.7% Topical application Lotion [Blue Lizard Active]


name: VORINOSTAT 1 g in 1 g NOT APPLICABLE POWDER


name: TIOPRONIN 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMPHENICOL 1 kg in 1 kg NOT APPLICABLE POWDER


name: urinary bag/catheter 14 Fr-8" MISCELL COMBINATION PACKAGE (EA)


name: troche base no.235 MISCELL POWDER (GRAM)


name: nutritional tx, ketogenic,whey 2.8 gram-104 kcal/100 mL ORAL LIQUID (ML)


name: nutritional therapy for propionic acidemia with iron 60 gram-297 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria (PKU) no.68 15 gram-330 kcal/81 gram ORAL BAR


name: compound vehicle suspension sugar-free no.25 ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: compound vehicle suspension sugar-free no.24 ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: COMBINATION PACK, CAPSULE AND CAPSULE DR


name: parenteral amino acid 15 % combination no.6


name: nutritional therapy for phenylketonuria(PKU) no.72


name: compounding vehicle suspension sugar free no.25


name: compounding vehicle suspension sugar free no.24


name: Lombardy poplar pollen extract / white poplar pollen extract


name: CATHERIZATION SET,INTERMITTENT 16FR BARD #4A8116


name: MEDICINE DOSE CUP,GRADUATED,METRIC ONLY,30ML


name: TRACH TUBE,SZ 8 BIVONA TTS SMITHS #670180


name: Kit for the Preparation of Indium In 111 Pentetreotide KIT


name: CATHETER FOLEY 3-WAY 24FR 5ML BARD #0119L24


name: CATHETER,INTERMITTENT,GENTLECATH 14FR FEMALE #509007


name: DRESSING,MEPILEX BORDER AG 9.2IN X 9.2IN #382490


name: CENTRAL LINE DRESSING CHANGE KIT,DEROYAL #47-276


name: DRESSING,OPTIFOAM GENTLE BORDER 3IN X 3IN #MSC2133


name: positive regulation of imaginal disc-derived wing size


name: serotonin-gated cation-selective signaling pathway


name: Bypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Open Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Synthetic Substitute, Open Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Nonautologous Tissue Substitute, Open Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Percutaneous Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Synthetic Substitute, Percutaneous Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Nonautologous Tissue Substitute, Percutaneous Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Autologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Synthetic Substitute, Percutaneous Endoscopic Approach


name: Bypass Cerebral Ventricle to Subgaleal Space with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Zooplastic Tissue, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Autologous Venous Tissue, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Autologous Arterial Tissue, Open Approach


name: Bypass Thoracic Aorta, Descending to Innominate Artery with Synthetic Substitute, Open Approach